Safe Orthopaedics Stock

Safe Orthopaedics Revenue 2024

Safe Orthopaedics Revenue

7.93 M EUR

Ticker

ALSAF.PA

ISIN

FR0013467123

WKN

A2PW9B

In 2024, Safe Orthopaedics's sales reached 7.93 M EUR, a 20.31% difference from the 6.59 M EUR sales recorded in the previous year.

The Safe Orthopaedics Revenue history

YEARREVENUE (undefined EUR)GROSS MARGIN (%)
2026e15.626,33
2025e8.8646,35
2024e7.9351,77
2023e6.5962,29
20225.8670,06
20214.5556,52
20203.6638,24
20194.727,22
20183.4743,39
20173.1144,41
20162.3733,23
20152.517,65
20142.0520,12
20130.973,09
20120.33-81,82

Safe Orthopaedics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Safe Orthopaedics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Safe Orthopaedics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Safe Orthopaedics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Safe Orthopaedics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Safe Orthopaedics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Safe Orthopaedics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Safe Orthopaedics’s growth potential.

Safe Orthopaedics Revenue, EBIT and net profit per share

DateSafe Orthopaedics RevenueSafe Orthopaedics EBITSafe Orthopaedics Net Income
2026e15.6 M undefined-5.99 M undefined-105,018.89 undefined
2025e8.86 M undefined-4.84 M undefined-83,504.16 undefined
2024e7.93 M undefined-5.25 M undefined-97,421.52 undefined
2023e6.59 M undefined-5.87 M undefined-167,008.31 undefined
20225.86 M undefined-5.96 M undefined-6.97 M undefined
20214.55 M undefined-7.58 M undefined-6.71 M undefined
20203.66 M undefined-6.67 M undefined-8.31 M undefined
20194.7 M undefined-7.45 M undefined-7.97 M undefined
20183.47 M undefined-6.15 M undefined-5.8 M undefined
20173.11 M undefined-5.43 M undefined-6.58 M undefined
20162.37 M undefined-6.29 M undefined-6.01 M undefined
20152.5 M undefined-7.22 M undefined-6.57 M undefined
20142.05 M undefined-5.57 M undefined-4.94 M undefined
2013970,000 undefined-3.09 M undefined-3.19 M undefined
2012330,000 undefined-3.43 M undefined-3.35 M undefined

Safe Orthopaedics stock margins

The Safe Orthopaedics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Safe Orthopaedics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Safe Orthopaedics.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Safe Orthopaedics's sales revenue. A higher gross margin percentage indicates that the Safe Orthopaedics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Safe Orthopaedics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Safe Orthopaedics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Safe Orthopaedics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Safe Orthopaedics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Safe Orthopaedics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Safe Orthopaedics Margin History

Safe Orthopaedics Gross marginSafe Orthopaedics Profit marginSafe Orthopaedics EBIT marginSafe Orthopaedics Profit margin
2026e70.06 %-38.43 %-0.67 %
2025e70.06 %-54.65 %-0.94 %
2024e70.06 %-66.23 %-1.23 %
2023e70.06 %-89.06 %-2.53 %
202270.06 %-101.76 %-118.84 %
202156.52 %-166.49 %-147.32 %
202038.24 %-182.23 %-227.06 %
201927.22 %-158.52 %-169.61 %
201843.39 %-177.18 %-167.1 %
201744.41 %-174.73 %-211.41 %
201633.23 %-265.84 %-253.91 %
201517.65 %-288.95 %-262.85 %
201420.12 %-271.12 %-240.43 %
20133.09 %-318.56 %-328.87 %
2012-81.82 %-1,039.39 %-1,015.15 %

Safe Orthopaedics Aktienanalyse

What does Safe Orthopaedics do?

Safe Orthopaedics SA is a leading company in the development and manufacturing of innovative medical devices for orthopedic surgery. The company was founded in 2010 by Pierre Dumouchel and Didier Toubia and has its main office in Eragny-sur-Oise, France. The company's business model is based on the development of products that can improve the lives of patients suffering from back injuries, osteoporosis, bone tumors, spinal trauma, or other orthopedic conditions. Safe Orthopaedics focuses on developing safe, easy-to-use, and cost-effective solutions for patient care. The company has several divisions, including the development and manufacturing of implantable spinal products and the development of innovative instruments for minimally invasive surgery. Safe Orthopaedics is also known for its custom surgical sets that are specifically tailored to the needs of its customers. Safe Orthopaedics offers a wide range of innovative products for orthopedic surgery. The company is particularly known for its spinal implants, including the SteriSpine® product range. The SteriSpine® system consists of a variety of sterile, implantable materials for use in spinal surgery. The system includes a variety of screws, plates, rods, and other implants that can be used to stabilize the spine in patients with spinal injuries or other conditions. Safe Orthopaedics also has an extensive portfolio of specialized instruments for minimally invasive surgery, enabling gentle and precise treatment. These include instruments such as the SteriFuse™ fusion tube, which allows for gentle fusion of vertebrae, or the SteriStay™, a device for stabilizing the spine. Custom surgical sets are also manufactured by Safe Orthopaedics. These sets are specifically tailored to the requirements of the corresponding spinal surgery, making the work of surgeons easier and contributing to patient safety. In 2019, Safe Orthopaedics acquired LCI Medical, a company specialized in the development of surgical instruments for minimally invasive spinal operations. By acquiring LCI Medical, Safe Orthopaedics expanded its range of products for minimally invasive spinal surgery and thus strengthened its competitiveness in the orthopedic surgery market. In conclusion, Safe Orthopaedics SA enables state-of-the-art technologies and innovative solutions for patients with orthopedic conditions. The company is committed to prioritizing patient safety and wellbeing while ensuring that surgical impact is minimized through the use of minimally invasive surgery. With its cutting-edge products and services, the company can offer a comprehensive range of solutions for spinal injuries while remaining particularly focused on the needs of patients and surgeons. Safe Orthopaedics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Safe Orthopaedics's Sales Figures

The sales figures of Safe Orthopaedics originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Safe Orthopaedics’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Safe Orthopaedics's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Safe Orthopaedics’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Safe Orthopaedics stock

How much revenue did Safe Orthopaedics generate this year?

Safe Orthopaedics has achieved a revenue of 7.93 M EUR this year.

How much was the turnover of the company Safe Orthopaedics compared to the previous year?

The revenue of Safe Orthopaedics has increased by 20.31% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Safe Orthopaedics?

The revenue of Safe Orthopaedics is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Safe Orthopaedics measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Safe Orthopaedics so important for investors?

The revenue of Safe Orthopaedics is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Safe Orthopaedics pay?

Over the past 12 months, Safe Orthopaedics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Safe Orthopaedics is expected to pay a dividend of 0 EUR.

What is the dividend yield of Safe Orthopaedics?

The current dividend yield of Safe Orthopaedics is .

When does Safe Orthopaedics pay dividends?

Safe Orthopaedics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Safe Orthopaedics?

Safe Orthopaedics paid dividends every year for the past 0 years.

What is the dividend of Safe Orthopaedics?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Safe Orthopaedics located?

Safe Orthopaedics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Safe Orthopaedics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Safe Orthopaedics from 11/1/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.

When did Safe Orthopaedics pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Safe Orthopaedics in the year 2023?

In the year 2023, Safe Orthopaedics distributed 0 EUR as dividends.

In which currency does Safe Orthopaedics pay out the dividend?

The dividends of Safe Orthopaedics are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Safe Orthopaedics

Our stock analysis for Safe Orthopaedics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Safe Orthopaedics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.